NCI’s Small Business Innovation Research (SBIR) Development Center released four new contract funding topics to advance work in the fields of wearable technologies, digital tools, and artificial intelligence (AI). You must submit your proposals by November 4, 2022, at 5:00 p.m. ET.

NCI expects to award 3­–5 opportunities worth up to $400,000 in the first 12 months (Phase I) and up to $2,000,000 in 2 years (Phase II).

The four new opportunities are:

• NIH/NCI 448—Wearable Devices for Dosimetry of Radiopharmaceutical Therapy
  • Goal: To develop wearable technologies (e.g., dosimetry sensor-incorporated clothing) to obtain data from patients receiving therapeutic radiopharmaceuticals. View the full contract solicitation.
• NIH/NCI 449—Wearable Technologies to Facilitate Remote Monitoring of Cancer Patients Following Treatment
  • Goal: To combine wearable sensors/other technologies with sophisticated analytical approaches and user interfaces to remotely monitor patients for cancer- or treatment-related adverse events (e.g., acute chemotherapy-induced toxicities). View the full contract solicitation.
• NIH/NCI 453—Digital Tools to Integrate Cancer Prevention Within Primary Care
  • Goal: To develop a centralized digital platform that can be readily integrated into primary care workflows and offer validated tools for screening, preventing, and treating cancer. View the full contract solicitation.
• NIH/NCI 454—Software to Evaluate Artificial Intelligence/Machine Learning Medical Devices in Oncology Settings
  • Goal: To encourage small business participation in the U.S. Food and Drug Administration’s Medical Device Development Tools Program, which is designed to develop methods for evaluating and monitoring AI and machine learning devices in oncology settings. View the full contract solicitation.

Need Help?

Not sure if your small business qualifies? Learn more about who is eligible to bid and to view sample applications. For inquiries, please email NCI's Office of Acquisition.